Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries. / Sheykhzade, Majid; Amandi, Nilofar; Pla, Monica Vidal; Abdolalizadeh, Bahareh; Sams, Anette; Warfvinge, Karin; Edvinsson, Lars; Pickering, Darryl S.

In: Vascular Pharmacology, Vol. 90, 10.02.2017, p. 36-43.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Sheykhzade, M, Amandi, N, Pla, MV, Abdolalizadeh, B, Sams, A, Warfvinge, K, Edvinsson, L & Pickering, DS 2017, 'Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries', Vascular Pharmacology, vol. 90, pp. 36-43. https://doi.org/10.1016/j.vph.2017.02.001

APA

Sheykhzade, M., Amandi, N., Pla, M. V., Abdolalizadeh, B., Sams, A., Warfvinge, K., Edvinsson, L., & Pickering, D. S. (2017). Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries. Vascular Pharmacology, 90, 36-43. https://doi.org/10.1016/j.vph.2017.02.001

Vancouver

Sheykhzade M, Amandi N, Pla MV, Abdolalizadeh B, Sams A, Warfvinge K et al. Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries. Vascular Pharmacology. 2017 Feb 10;90:36-43. https://doi.org/10.1016/j.vph.2017.02.001

Author

Sheykhzade, Majid ; Amandi, Nilofar ; Pla, Monica Vidal ; Abdolalizadeh, Bahareh ; Sams, Anette ; Warfvinge, Karin ; Edvinsson, Lars ; Pickering, Darryl S. / Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries. In: Vascular Pharmacology. 2017 ; Vol. 90. pp. 36-43.

Bibtex

@article{7a1d49639bf04db285caf0a0beed8d71,

title = "Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries",

abstract = "AIM: The neuropeptide calcitonin gene-related peptide (CGRP) is found in afferent sensory nerve fibers innervating the resistance arteries and plays a pivotal role in a number of neurovascular diseases such as migraine and subarachnoid bleedings. The present study investigates the binding and antagonistic characteristics of small non-peptide CGRP receptor antagonists (i.e. gepants) in isolated rat brain and mesenteric resistance arteries.METHODS: The antagonistic behavior of gepants was investigated in isolated rat mesenteric arteries using a wire myograph setup while binding of gepants to CGRP receptors was investigated in rat brain membranes using a radioligand competitive binding assay. Furthermore, the histological location of the key components of CGRP receptor (RAMP1 and CLR) was assessed by immunohistochemistry.RESULTS: Our functional studies clearly show that all gepants are reversible competitive antagonists producing Schild plot slopes not significantly different from unity and thus suggesting presence of a uniform CGRP receptor population in the arteries. A uniform receptor population was also confirmed by radioligand competitive binding studies showing similar affinities for the gepants in rat brain and mesenteric arteries, the exception being rimegepant which had 50-fold lower affinity in brain than mesenteric arteries. CLR and RAMP1 were shown to be located in both vascular smooth muscle and endothelial cells of rat mesenteric arteries by immunohistochemistry.CONCLUSION: The present results indicate that, despite species differences in the CGRP receptor affinity, the antagonistic nature of these gepants, the distribution pattern of CGRP receptor components and the mechanism behind CGRP-induced vasodilation seem to be similar in resistance-sized arteries of human and rats.",

keywords = "Journal Article",

author = "Majid Sheykhzade and Nilofar Amandi and Pla, {Monica Vidal} and Bahareh Abdolalizadeh and Anette Sams and Karin Warfvinge and Lars Edvinsson and Pickering, {Darryl S}",

year = "2017",

month = feb,

day = "10",

doi = "10.1016/j.vph.2017.02.001",

language = "English",

volume = "90",

pages = "36--43",

journal = "Vascular Pharmacology",

issn = "1537-1891",

publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries

AU - Sheykhzade, Majid

AU - Amandi, Nilofar

AU - Pla, Monica Vidal

AU - Abdolalizadeh, Bahareh

AU - Sams, Anette

AU - Warfvinge, Karin

AU - Edvinsson, Lars

AU - Pickering, Darryl S

PY - 2017/2/10

Y1 - 2017/2/10

N2 - AIM: The neuropeptide calcitonin gene-related peptide (CGRP) is found in afferent sensory nerve fibers innervating the resistance arteries and plays a pivotal role in a number of neurovascular diseases such as migraine and subarachnoid bleedings. The present study investigates the binding and antagonistic characteristics of small non-peptide CGRP receptor antagonists (i.e. gepants) in isolated rat brain and mesenteric resistance arteries.METHODS: The antagonistic behavior of gepants was investigated in isolated rat mesenteric arteries using a wire myograph setup while binding of gepants to CGRP receptors was investigated in rat brain membranes using a radioligand competitive binding assay. Furthermore, the histological location of the key components of CGRP receptor (RAMP1 and CLR) was assessed by immunohistochemistry.RESULTS: Our functional studies clearly show that all gepants are reversible competitive antagonists producing Schild plot slopes not significantly different from unity and thus suggesting presence of a uniform CGRP receptor population in the arteries. A uniform receptor population was also confirmed by radioligand competitive binding studies showing similar affinities for the gepants in rat brain and mesenteric arteries, the exception being rimegepant which had 50-fold lower affinity in brain than mesenteric arteries. CLR and RAMP1 were shown to be located in both vascular smooth muscle and endothelial cells of rat mesenteric arteries by immunohistochemistry.CONCLUSION: The present results indicate that, despite species differences in the CGRP receptor affinity, the antagonistic nature of these gepants, the distribution pattern of CGRP receptor components and the mechanism behind CGRP-induced vasodilation seem to be similar in resistance-sized arteries of human and rats.

AB - AIM: The neuropeptide calcitonin gene-related peptide (CGRP) is found in afferent sensory nerve fibers innervating the resistance arteries and plays a pivotal role in a number of neurovascular diseases such as migraine and subarachnoid bleedings. The present study investigates the binding and antagonistic characteristics of small non-peptide CGRP receptor antagonists (i.e. gepants) in isolated rat brain and mesenteric resistance arteries.METHODS: The antagonistic behavior of gepants was investigated in isolated rat mesenteric arteries using a wire myograph setup while binding of gepants to CGRP receptors was investigated in rat brain membranes using a radioligand competitive binding assay. Furthermore, the histological location of the key components of CGRP receptor (RAMP1 and CLR) was assessed by immunohistochemistry.RESULTS: Our functional studies clearly show that all gepants are reversible competitive antagonists producing Schild plot slopes not significantly different from unity and thus suggesting presence of a uniform CGRP receptor population in the arteries. A uniform receptor population was also confirmed by radioligand competitive binding studies showing similar affinities for the gepants in rat brain and mesenteric arteries, the exception being rimegepant which had 50-fold lower affinity in brain than mesenteric arteries. CLR and RAMP1 were shown to be located in both vascular smooth muscle and endothelial cells of rat mesenteric arteries by immunohistochemistry.CONCLUSION: The present results indicate that, despite species differences in the CGRP receptor affinity, the antagonistic nature of these gepants, the distribution pattern of CGRP receptor components and the mechanism behind CGRP-induced vasodilation seem to be similar in resistance-sized arteries of human and rats.

KW - Journal Article

U2 - 10.1016/j.vph.2017.02.001

DO - 10.1016/j.vph.2017.02.001

M3 - Journal article

C2 - 28192258

VL - 90

SP - 36

EP - 43

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

ER -

ID: 173384350